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Study Objectives: To characterize sleep duration, timing and continuity measures in pregnancy and their association with key demographic variables.
Methods: Multisite prospective cohort study. Women enrolled in the nuMoM2b study (nulliparous women with a singleton gestation) were recruited at the second 
study visit (16–21 weeks of  gestation) to participate in the Sleep Duration and Continuity substudy. Women <18 years of  age or with pregestational diabetes or 
chronic hypertension were excluded from participation. Women wore a wrist activity monitor and completed a sleep log for 7 consecutive days. Time in bed, sleep 
duration, fragmentation index, sleep efficiency, wake after sleep onset, and sleep midpoint were averaged across valid primary sleep periods for each participant.
Results: Valid data were available from 782 women with mean age of  27.3 (5.5) years. Median sleep duration was 7.4 hours. Approximately 27.9% of  women 
had a sleep duration of  <7 hours; 2.6% had a sleep duration of  >9 hours. In multivariable models including age, race/ethnicity, body mass index, insurance 
status, and recent smoking history, sleep duration was significantly associated with race/ethnicity and insurance status, while time in bed was only associated 
with insurance status. Sleep continuity measures and sleep midpoint were significantly associated with all covariates in the model, with the exception of  age for 
fragmentation index and smoking for wake after sleep onset.
Conclusions: Our results demonstrate the relationship between sleep and important demographic characteristics during pregnancy.
Keywords: pregnancy, sleep duration, sleep quality, epidemiology.
INTRODUCTION
Poor sleep quality is common in the general population, and 
women are more likely to have sleep disturbances than are 
men.1 Poor sleep quality, defined here, as inadequate sleep 
duration and poor sleep continuity, can be the result of environ-
mental and psychosocial factors, medical and psychiatric disor-
ders, as well as sleep disorders such as insomnia, sleep apnea, 
and restless legs syndrome. There are mounting data linking 
poor sleep quality and adverse health outcomes. Experimental 
studies show that sleep restriction and fragmentation adversely 
affect appetite-regulating hormones, insulin sensitivity, mark-
ers of systemic inflammation, and autonomic regulation and 
function,2–5 while epidemiologic studies demonstrate that short 
sleep duration is associated with an increased risk of obesity, 
diabetes, hypertension, and mortality.6–12 Sleep duration in non-
pregnant individuals has also been associated with cardiomet-
abolic risk factors including age, body mass index, smoking, 
race/ethnicity, and socioeconomic status.13,14 There is also a 
link between later sleep timing and unhealthy behaviors such as 
smoking, alcohol use, and poor diet.15,16
Recent studies suggest that pregnant women are a popula-
tion at particularly increased risk for sleep disturbances.17–19 
However, most of these studies are conducted in select popu-
lations and have relied on self-reported sleep measures, which 
may overestimate sleep duration compared to objective sleep 
measures.17,20–23 Those studies using actigraphy typically have 
less than 200 women and are often samples of convenience 
from a small geographic area.21,24–26 One actigraphy-based 
study of 80 urban, low-income women reported a mean actigra-
phy-based sleep duration of 6.8 hours in comparison to a mean 
self-reported sleep duration of 7.2 hours.21 Another more recent 
study, examining sleep across pregnancy using actigraphy, 
reported a mean second-trimester sleep duration of 6.6 hours.25 
Another important factor is that simply focusing on sleep dura-
tion ignores other characteristics of sleep such as sleep conti-
nuity, sleep timing, and variability, despite growing evidence 
Statement of Significance
The current study represents one of  the largest cohorts of  objectively measured habitual sleep in pregnancy to date and demonstrates the feasibility 
of  objectively assessing sleep over a week during pregnancy. Our data indicate that, in the second trimester of  nulliparous pregnancy, sleep duration, 
continuity, and timing of  sleep are associated with multiple demographic characteristics. Furthermore, more than 20% of  women had a sleep duration that 
has previously been shown in nonpregnant cohorts to be associated with poor cardiometabolic health.
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regarding the multidimensional nature of healthy sleep.27,28 
To date, systematic population-based prospective studies to 
determine the type and prevalence of sleep problems during 
pregnancy, and their association with patient demographic and 
behavioral characteristics, are lacking.
The Nulliparous Pregnancy Outcome Study: Monitoring 
Mothers-to-be (nuMoM2b) is a prospective cohort study of 
nulliparous women with singleton gestations. Enrolled women 
underwent research assessments over the course of their preg-
nancies to study the mechanisms and predictive factors of 
adverse pregnancy outcomes including hypertensive disease 
of pregnancy, preterm birth, and fetal growth restriction.29 
The nuMoM2b Sleep Duration and Continuity Substudy is 
a prospective study of a subset of the women enrolled in the 
nuMoM2b parent study. The primary objective of this Substudy 
was to examine the relationship of objectively assessed sleep 
duration, continuity, and timing, with cardiovascular and meta-
bolic morbidity related to pregnancy.
This article describes sleep duration, sleep timing, sleep con-
tinuity, and sleep variability measures in pregnancy and their 
association with important demographic characteristics as well 
as the detailed methods for actigraphy acquisition and scoring 
used in the nuMoM2b Sleep Duration and Continuity Substudy.
METHODS
General Design nuMoM2b Parent Study
Details of the nuMoM2b parent study have been previously pub-
lished.29 The nuMoM2b study was conducted at 8 clinical sites 
from 2010 through 2013: Case Western Reserve University, 
Columbia University, Indiana University, the University 
of Pittsburgh, Northwestern University, the University of 
California at Irvine, the University of Pennsylvania, and the 
University of Utah. Data were managed by a central data 
coordinating and analysis center (RTI International). Briefly, 
the nuMoM2b study was a prospective cohort of nulliparous 
women (no prior delivery at ≥20 weeks gestational age), with 
a viable singleton pregnancy at the time of screening between 
60–136 weeks’ gestation. Study visits were conducted at 4 times 
antepartum (Visits 1–4): 60–136, 160–216 and 220–296 weeks’ 
gestation as well as at the time of delivery. Data were collected 
through interviews, self-administered questionnaires, clinical 
measurements, ultrasounds, and medical records review to 
obtain pertinent demographic, psychosocial, dietary, physio-
logic, and outcome information. In addition, maternal serum, 
plasma, urine, and cervicovaginal fluid were collected at each 
visit; maternal blood for DNA was collected at Visit 1; and 
cord blood and placental samples were collected at delivery. All 
types of samples were stored in a repository for later use.
General Design of nuMoM2b Sleep Duration and Continuity 
Substudy
Women were recruited into the Sleep Duration and Quality 
Substudy at the second nuMoM2b study visit (160–216 weeks of 
gestation) from 2011 through 2013. As part of this nuMoM2b 
Substudy, women were asked to wear a wrist actigraphy moni-
tor (Spectrum, Phillips Respironics) for 7 consecutive days and 
to complete a daily sleep log. The 7 days of rest–activity col-
lection was completed prior to 230 weeks of gestation. Women 
were compensated for participation with a $20 gift card. All 
actigraphy data were scored by a central reading center located 
at Northwestern University. The primary aim of the Sleep 
Duration and Quality Substudy was to determine the associa-
tion between sleep quality and the pregnancy outcomes of ges-
tational hypertension, preeclampsia, and gestational diabetes.
Prior to participation in the Substudy, women gave writ-
ten informed consent. The Substudy was approved by the 
Institutional Review Board at each of the participating sites and 
the data coordinating center prior to initiation.
Study Population
The nuMoM2b study protocol included nulliparous women 
who were at least 13 years of age, although, in the Sleep 
Duration and Continuity Substudy, participants under 18 years 
of age were excluded. The decision to include only those aged 
18 years and older was made because sleep characteristics are 
significantly different between children (<18 years of age) and 
adults, and there were not a sufficient number of women less 
than 18 years of age to meaningfully adjust for this difference 
in analysis.30–32 In addition, while the parent study included 
women with chronic hypertension, these women were excluded 
from this substudy, given the difficulty in accurately diagnos-
ing a new-onset hypertensive disorder in women with preexist-
ing hypertension. Women with preexisting diabetes were also 
excluded, as they cannot be diagnosed with gestational diabetes.
Demographic Characteristics
Except for gestational age at screening, baseline demographic 
data were collected in early pregnancy (6–13 weeks’ gestation). 
Insurance status was created as follows: If the participant indi-
cated that her health care was paid for by commercial health 
insurance/commercial Health Maintenance Organization, then 
insurance status was set to Commercial. Otherwise if the par-
ticipant indicated that her health care was paid for by gov-
ernment insurance, military insurance, personal household 
income, or other, then insurance status was set to Government/
Self-pay.
Sleep Log
Participants were asked to maintain daily sleep logs for 7 con-
secutive days and to record bedtime, wake time, total sleep 
time, sleep latency, wake after sleep onset (WASO), naps, any 
unusual events during the day or night, overall sleep quality, and 
whether it was a free day or work/school day. The sleep log was 
a modified version of the Karolinska Sleep Log.33 Participants 
were instructed to complete the sleep log every day within 1 
hour of waking. Participants were encouraged to keep the sleep 
log next to their place of sleep so that they would not forget to 
fill out the log each day. The first page of the sleep log packet 
was an example page, and study personnel were instructed 
to complete this page with the participant. Study personnel 
marked the rest of the pages with the date and day of the week 
when they should be completed.
Data from all sleep logs that were returned were entered by 
a research technician into a data management system devel-
oped and managed by RTI. Each entry was checked by a 
separate research assistant, and any disagreements between 
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initial data and quality control review were adjudicated by a 
third party.
Actigraphy
Participants were instructed that the rest–activity monitor 
should be worn on and securely fastened around the nondomi-
nant wrist, just as a “wrist-watch” would be worn. Participants 
were instructed to press the event markers when going to bed 
for their main sleep period (i.e., when turning off the light or 
trying to fall asleep), when waking up in the morning, and 
when taking naps or falling asleep for more than 5 minutes. An 
actigraphy recording was considered successful if, during the 
7 days of the study, there were at least 5 primary sleep periods 
recorded (out of a possible 7), there was less than 4 hours of off-
wrist time during the 24-hour periods containing the included 
primary sleep periods, and there was no off-wrist time during 
the sleep period. If a participant’s study data did not meet these 
criteria, she was asked to wear the watch again for an additional 
week as long as the recording could be completed by 230 weeks. 
Actiwatches were configured using Actiware Sleep V5.59 
(Phillips-Respironics, Mini Mitter, Bend, OR) to record epochs 
with a 30-second duration and the presence of red, green, and 
blue light. The activity threshold was set at medium (i.e., 40 
activity counts).
Training of Study Personnel at Each Site
Study personnel from all study sites attended an in-person train-
ing session held at RTI before recruitment began to review the 
operation of study equipment and other study procedures. This 
session was conducted by study investigators and a represent-
ative from Phillips Respironics. Study personnel at all sites 
were certified by the Actigraphy Reading Center after passing a 
written test and demonstrating successful transmission of valid 
actigraphy data and sleep logs.
Analysis and Scoring of Actigraphy
All actigraphy files and sleep log data were securely transmitted 
to the Actigraphy Reading Center. Actigraphy data were ana-
lyzed with Actiware Sleep V5.59. Data were processed through 
the Actiware Sleep scoring algorithm. The default setting was 
used and is presented in this article. The default scoring algo-
rithm was set with 10 minutes of immobile time for sleep start, 
in reference to the set rest start, and 10 minutes of immobile 
time for sleep end, in reference to the set rest end.
Scoring Method
The analysis algorithm calculates sleep/wake within defined 
rest intervals, and these rest intervals were manually set by a 
trained technician using the event markers (EM) and/or sleep 
log entries (SL) when available. If neither an event marker nor 
sleep log was available, or if either were clearly inaccurate, the 
trained technician set the rest interval based on a reduction in 
activity and light levels.34,35 All technician-scored rest intervals 
were reviewed by another scorer.
Each rest interval start and end was given a value ranging 
from 1 to 4 (with “1” indicating the data with the best concord-
ance) that coincided with the cues that were used to set that 
interval. For example, if there was good concordance between 
the event marker, sleep diary, and a drop in the activity level, 
the interval would be given a value of 1. The number of primary 
sleep periods for each code is presented in the results section, 
but they were not used in the analysis. Details of the criteria 
used to code the rest intervals are outlined below.
1. If the start and/or end of a given rest interval had a time 
from the event markers (EM) and the sleep log (SL) that 
were within 15 minutes of each other and the actual activity 
reflected rest, it was assigned a score of 1.
2. If the start and/or end of a given rest interval had an EM 
that differed from the SL entry by more than 15 minutes, 
it received a score of 2 (provided the EM was supported by 
activity level).
3. If the start and/or end of a given rest interval had an SL that 
was in agreement with the drop in activity level and the EM 
was considered unreliable or absent, it received a score of 3.
4. In situations where the EM and SL were (a) completely 
absent, (b) present but in poor agreement with the activity 
drop/rise, or (c) limited to only one EM or SL entry either at 
the beginning or at the end of the rest interval, it received a 
score of 4. This score implies that the interval was set by the 
technician’s judgment based on the information available.
In addition to activity level, the device has the capability of 
recording photopic light, so when a study was “level 4,” the 
technician also used light level as a guide to set the rest inter-
vals.36 To illustrate, in order to set the start of the rest inter-
val, the technician would coalesce the drop in light level with a 
sequential series of activity counts that were <200 for a 5-min-
ute period.37 Conversely, in order to determine the end of the 
rest interval, the first epoch in a consecutive 5-minute sequence 
of nonzero counts >200 was used along with an accompanying 
rise in light level.
Review of Actigraphy Scoring
All studies were scored by a single experienced technician 
(MH). For studies with minor (<30 minutes) disagreement 
between the EMs or SLs and with actual activity/light levels, a 
second trained scorer reviewed the study, and if there was fur-
ther disagreement in the study score, the study was adjudicated 
further by the reading center director (KJR) who made the final 
decision on rest interval placement. For studies with more than 
30 minutes disagreement between the EMs and SLs with actual 
activity/light levels, the reading center director made the final 
decision on rest interval placement (typically these would be 
given a scoring value of 4). Also, all intervals given a value/
score of 4 were reviewed by the reading center director. As a 
final check, all scored actograms were printed in color and vis-
ually reviewed by the reading center director.
Actigraphy-Derived Sleep Variables
The primary and secondary measures used to assess the 
domains of sleep duration and sleep continuity were as follows: 
time in bed, sleep duration, sleep fragmentation index (FI), 
sleep efficiency, WASO, and sleep midpoint. Data from the pri-
mary sleep period from all available valid days were averaged 
to provide a single value for each measure for each participant. 
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Time in bed was defined as the time between the start and end of 
the rest interval. Sleep duration was defined as the total amount 
of time scored as sleep, by the Actiware algorithm, during the 
main sleep period. Insufficient sleep was defined as a mean of 
<7 hours of sleep/night in the main sleep period, based on the 
consensus statement given by the American Academy of Sleep 
Medicine and Sleep Research Society31 and prior research by 
the authors.38 Sleep fragmentation index, sleep efficiency, and 
WASO provide measures of sleep quality. The sleep fragmen-
tation index is calculated as the proportion of all epochs from 
sleep onset to sleep offset with an activity count of 2 or greater 
plus the proportion of all bouts of immobility (activity count 
less than 2 in every epoch) that were 1 minute or less in dura-
tion.39,40 Sleep efficiency is calculated as the proportion of time 
from rest start to rest end scored as sleep. WASO is the total 
amount of minutes spent awake between sleep onset and the 
end of the rest interval. Sleep midpoint is the clock time that 
represents the midpoint between the clock time of sleep onset 
and the clock time of sleep offset. For each woman, the standard 
deviation value of time in bed, sleep duration, and sleep mid-
point was calculated across the week of recording.41,42
Sample Size for Primary Outcome Analysis
The primary outcome measures for the Sleep Duration and 
Continuity Substudy are maternal cardiovascular and meta-
bolic morbidity related to pregnancy. The reported prevalence 
of gestational diabetes ranges from 1.4% to 14%, gestational 
hypertension from 4% to 6%, and preeclampsia from 3% to 
8%.43,44 From prior data, we estimated a prevalence of short 
sleep duration of 25%.18 In nonpregnant individuals, short sleep 
duration has been associated with a 1.5- to 4-fold increased 
risk of cardiovascular and metabolic disease.45,46 Power calcu-
lations for detectable effect sizes (relative risk) for short sleep 
duration assessed by actigraphy are presented in Table 1. The 
power calculations take into account an outcome prevalence of 
8–12%, an N of 760 subjects, a 5% level of statistical signif-
icance (2-sided), and an R2 value of 0.01 for the association 
between the categorical exposure and the covariates included in 
a logistic regression model.47
Statistical Analysis
In this report, in addition to describing the study methods, we 
provide a descriptive analysis of the actigraphy data and exam-
ine sleep duration, sleep continuity, and sleep timing meas-
ures in relation to maternal age, race/ethnicity, body mass 
index (BMI), insurance status, and recent smoking history. 
Demographic characteristics were categorized and medians 
and interquartile ranges (IQRs) for sleep actigraphy measures 
were compared for each demographic characteristic tested 
using Kruskal-Wallis tests. For multivariable analyses, the main 
effects of association of the demographic characteristics with 
the sleep actigraphy measures were evaluated using F-tests 
associated with type III sums of squares from analysis of var-
iance models. The actigraphy measures are analyzed on the 
original (time in bed and sleep duration) or, in some cases, a 
transformed scale to better satisfy normality assumptions of the 
model. For sleep fragmentation, WASO, and sleep midpoint, a 
log transform was used, while sleep efficiency was cubed. All 
tests were performed at a nominal significance level of α = .05. 
No corrections are made for multiple comparisons. Analyses 
were conducted using SAS/STAT 9.3 and 9.4 software (SAS 
Institute Inc, Cary, North Carolina).
RESULTS
A total of 901 women in nuMoM2b enrolled in the Sleep 
Duration and Continuity Substudy. Valid actigraphy data were 
available for 782 (86.8%) women, 759 of whom also returned a 
sleep log (Table 2). There were 119 (13.2%) invalid studies. The 
two most frequent reasons for the invalid studies were partici-
pant noncompliance (60%, watch not worn at least 20 hours/day 
for at least 5 days) and watch failure (40%). Watch failure was 
primarily due to one of the following reasons: faulty off-wrist 
detection, a corrupted database, or constant low-level activity 
counts.
Baseline demographic characteristics of the 782 women 
with actigraphy data are presented in Table 3. The mean age 
of the women at entry into the Substudy was 27.3 years (stand-
ard deviation 5.5 years). Sixty-three percent (63.4%) of the 
women were non-Hispanic white, 11.8% were non-Hispanic 
black, 15.6% were Hispanic, 3.6% were Asian, and 5.6% were 
classified as “other” on race/ethnicity. Fourteen percent of 
the sample were neither employed or in school and 15% had 
less than a college education. Women were classified by their 
prepregnancy BMI as follows: 50.7% of women were normal 
Table 1—Statistical Power for Detection of  Effect Size (Relative Risk) for 
Short Sleep Duration (SSD).
Composite outcome rate Difference  
in rates
Relative  
risk
Powera
Without SSD With SSD
0.08 0.12 50% 1.5 0.40
0.08 0.16 100% 2.0 0.86
0.10 0.15 50% 1.5 0.48
0.10 0.20 100% 2.0 0.93
0.12 0.18 50% 1.5 0.55
0.12 0.24 100% 2.0 0.97
aAssuming N = 760 participants included in the evaluation, 25% prev-
alence of  SSD, an R2 = 0.01 for association of  SSD (categorical) with 
covariates included in the logistic regression model, and Type I error 
(2-sided) = 0.05.
Table 2—Actigraphy Assessment.
Characteristic n (%)
Eligible participants 901
 Valid sleep actigraphy studies 782 (86.8)
 Valid actigraphy with sleep log returned 759 (84.2)
 Invalid actigraphy studies 119 (13.2)
  Off  wrist > 4 hours (participant noncompliance) 71 (60.0)
  Watch failure 48 (40.0)
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weight (BMI 18.5–24.9 kg/m2), 25.1% were overweight (BMI 
25.0–29.9 kg/m2), 21.5% were obese or morbidly obese (BMI 
≥ 30 kg/m2), and 2.7% were underweight (BMI < 18.5 kg/m2). 
Approximately fourteen percent (14.5%) of the participants 
smoked during the 3 months prior to the pregnancy.
A summary of the characteristics of weekday/weekend, work/
school, and nonwork/nonschool day, and scoring methods is 
provided in Table 4. Seventy-seven percent of women con-
tributed 7 valid days of actigraphy data. Seventy-nine percent 
of women had actigraphy data collected on at least one work/
school day. Only 2% of the sample had no data collected on 
nonwork/nonschool days. Of a total of 5253 primary sleep peri-
ods, 85% had an event marker and/or sleep log entry for scoring 
and 15% required technician only scoring.
Actigraphic measures of sleep duration, continuity, timing, 
and variability stratified by age, race, BMI, insurance status, 
and recent smoking history are provided in Tables 5 and 6. 
Overall, the median (IQR) of time in bed was 8.7 (1.1) hours 
and of sleep duration was 7.4 (1.0) hours, with 42.2 (23.4) min-
utes of WASO and a sleep midpoint of 3:38 am (100 minutes). 
Twenty-eight percent (27.9%) of women had a sleep duration 
of <7 hours and 2.6% had a sleep duration of >9 hours. Time 
in bed was associated with age and insurance status; it was 
longer for younger women and those with government/self-pay 
insurance. Sleep duration was significantly different by race/
ethnicity, with non-Hispanic blacks and Asian women hav-
ing the shortest sleep durations. The three measures of sleep 
continuity (sleep fragmentation, sleep efficiency, wake after 
sleep onset) and sleep midpoint were significantly related to all 
demographic characteristics (maternal age, BMI, race/ethnicity, 
insurance status, and recent smoking history).
The standard deviation as a measure of variability in sleep 
across the recording period was also assessed for time in bed, 
sleep duration, and sleep midpoint for each individual and strat-
ified by baseline characteristics and is provided in Table 6. In 
the overall sample, more than 50% of women had a standard 
deviation in sleep duration that was over an hour across the 
week of recording, while sleep midpoint varied by more than 
40 minutes. The three measures of sleep variability included 
in this analysis were significantly related to all demographic 
Table 3—Baseline Characteristicsa.
Characteristic (N = 782) Statistic
Estimated gestational age at screening, n (%)
 <8 weeks 0 days 11 (1.4)
 8 weeks 0 days to 9 weeks 6 days 78 (10.0)
 10 weeks 0 days to 11 weeks 6 days 236 (30.2)
 12 weeks 0 days to 13 weeks 6 days 457 (58.4)
Maternal age, years
 Mean (standard deviation) 27.3 (5.5)
 Median (interquartile range) 27.0 (23, 31)
Category, n (%)
 <22 148 (18.9)
 22–35 573 (73.3)
 >35  61 (7.8)
Maternal race/ethnicity, n (%)
 Non-Hispanic white 496 (63.4)
 Non-Hispanic black  92 (11.8)
 Hispanic  122 (15.6)
 Asian  28 (3.6)
 Other  44 (5.6)
Maternal education status, n (%)
 Less than high school 28 (3.6)
 Completed high school or GED 89 (11.4)
 Some college 176 (22.5)
 Associate or technical degree 87 (11.1)
 Completed college 210 (26.9)
 Degree work beyond college 192 (24.6)
Employment/school status, n (%)
 Employed and in school  116 (15.6)
 Employed and not in school  474 (63.9)
 Unemployed and in school 48 (6.5)
 Unemployed and not in school 104 (14.0)
Insurance status, n (%)b
 Government insurance 188 (24.2)
 Military insurance  2 (0.3)
 Commercial health insurance 564 (72.5)
 Personal household income  150 (19.3)
 Other  9 (1.2)
BMI
 Underweight (<18.5) 21 (2.7)
 Normal Weight (18.5–24.9) 391 (50.7)
 Overweight (25.0–29.9) 194 (25.1)
 Obese (30.0–34.9) 98 (12.7)
 Morbidly Obese (>35) 68 (8.8)
Ever smoked, n (%) 322 (41.2)
Smoked during 3 months prior to pregnancy, n (%) 113 (14.5)
 Among smokers during 3 months prior to pregnancy
  Cigarettes per day: n (%)  
  <20 cigarettes per day 99 (87.6)
  20–40 cigarettes per day 14 (12.4)
  >40 cigarettes per day 0 (0.0)
Abbreviation: BMI, body mass index.
aExcept for gestational age at screening, baseline data were collected in 
early pregnancy (6–13 weeks’ gestation).
bPercentages do not add up to 100% as participants were allowed to 
select multiple methods of  payment for healthcare.
Table 3—Continued
6SLEEP, Vol. XX, No. X, 2017 Sleep During Pregnancy nuMoM2b Substudy—Reid et al.
characteristics examined including maternal age, BMI, race/
ethnicity, insurance status, and recent smoking history.
After adjustment for the other baseline characteristics (age, 
race/ethnicity, education, employment, insurance status, BMI, 
and recent smoking history), time in bed remained associated 
with insurance status, and sleep duration remained associated 
with race/ethnicity and insurance status. Sleep midpoint and all 
sleep continuity measures (with the exception of age for sleep 
fragmentation index and smoking for wake after sleep onset) 
remained associated with age, race/ethnicity, BMI, insurance 
status, and recent smoking history.
After adjustment, the standard deviation of time in bed and 
sleep duration remained significantly associated with all of the 
baseline characteristics (age, race/ethnicity, BMI, and recent 
smoking history) except insurance status while for the standard 
deviation of sleep midpoint only age remained significant.
DISCUSSION
In this initial report of the nuMoM2b Sleep Duration and 
Continuity Substudy, we have provided a descriptive analysis 
of our actigraphy data. Our results demonstrate the relationship 
between sleep variables and important baseline demographic 
characteristics.
Sleep disturbance is common in pregnancy18; however, there 
are limited objective sleep data available in this population. The 
current study represents one of the largest cohorts of objec-
tively measured habitual sleep in pregnancy to date. Although 
the women in this study spent a median of 8.7 hours in bed for 
their primary sleep period each day, sleep efficiency was low, 
with a median sleep duration of 7.4 hours. In addition, sleep 
continuity and midpoint were significantly associated with age, 
BMI, race/ethnicity, insurance status, and recent smoking his-
tory; sleep duration varied only by race/ethnicity and insurance 
status.
Several studies have now shown that in nonpregnant adults 
both long (i.e., >8.5 hours) and short sleep duration (i.e., < 7 
hours) are associated with poor cardiometabolic health.13,31 
There is also some evidence, from small studies using self-re-
ported sleep measures, to suggest that short sleep is associated 
with an increased frequency of poor pregnancy outcomes.38,48 
Although the sleep duration in this cohort is longer than that 
reported for pregnant women in other studies,24,26 of note is that 
27.9% of the women in this cohort had a sleep duration of <7 
hours, and 2.9% had a sleep duration of > 9 hours. In a recent 
consensus statement given by the American Academy of Sleep 
Medicine and Sleep Research Society, it is recommended that 
adults regularly obtain 7 or more hours of sleep a night to pro-
mote optimal health.31
Sleep duration is not the only measure of sleep health.27 
Disrupted sleep continuity may be just as important a risk fac-
tor for poor cardiometabolic health as short sleep duration. In 
healthy young adults, experimental fragmentation of sleep, 
without a reduction in sleep duration, has been shown to be 
associated with alterations in glucose metabolism.49 In other 
population-based studies using actigraphy, fragmentation index 
(FI) has also been associated with significant differences in 
measures of metabolic function such as fasting insulin and glu-
cose as well as insulin resistance.50 There are several ways to 
measure sleep continuity and in this study, we report WASO, 
fragmentation index, and sleep efficiency.
Women in this study spent a relatively long time in bed 
attempting to sleep, with WASO accounting for the majority of 
the difference between time in bed and sleep duration. In fact, 
50% of the sample had a WASO of >42 minutes. In pregnant 
women, a WASO ≥30 minutes has been shown to be associated 
with significant alterations in blood pressure.24 Other studies of 
adults have shown that a long WASO is associated with depres-
sive symptoms and cognitive decline. While WASO is a useful 
measure, it simply reflects how much time a person spent awake 
Table 4—Actigraphy Data Quality Summary.
Characteristic Statistic
Valid number of  days recorded for n = 782 participants
 Total n (%) 5 41 (5)
6 139 (18)
7 602 (77)
Mean (SD) 6.7 (0.6)
 Work/school days: n (%) None 164 (21)
1-3 199 (25)
4 or 
more
419 (54)
Mean (SD) 3.1 (2.0)
 Nonwork/school days: n (%) None 16 (2)
1-2 295 (38)
3 or 
more
471 (60)
Mean (SD) 3.6 (2.0)
 Week days: n (%) 3 25 (3)
4 125 (16)
5 631 (81)
6 1 (0)
Mean (SD) 4.8 (0.5)
 Weekend days: n (%) 0 1 (0)
1 51 (7)
2 724 (93)
3 6 (1)
Mean (SD) 1.9 (0.3)
Score method summary for n = 5,253  
primary sleep intervals, n (%)
  Matching marker and diary (1) used  
for start and end
1774 (34)
 Marker (2) used for start & end 1207 (23)
 Diary (3) used for start & end 1102 (21)
  Different method (marker/diary) used for  
start & end
361 (7)
 Technician (4) assigned start & end 809 (15) 
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after initially falling asleep, and it does not provide information 
on how fragmented the sleep was during this time. For example, 
a person who is awake for 50 consecutive minutes, and a person 
awake 10 times for 5 minutes each time, would both have a 
WASO of 50 minutes. The consequences for sleep architecture 
in these scenarios is likely considerably different. The FI is an 
additional measure of the degree of sleep disturbance that has 
been shown to be associated with cardiometabolic health. The 
median FI in the nuMoM2b Substudy was 17.5%. In a group 
of diabetic women with a mean FI of 20%, a 10% increase in 
FI was associated with 43% greater insulin resistance even in a 
fully adjusted model.50
In addition to sleep duration and continuity, there are other 
measures of sleep that have been shown to be associated with 
health and health behaviors, such as sleep timing and variability 
in sleep measures from day-to-day. The median sleep midpoint, 
a measure of sleep timing, reported in this study of pregnant 
women is similar to that previously reported for adults,15,51 
while the variability in sleep duration and timing are similar to 
that reported in older adults with insomnia.41,42
In addition to describing sleep during pregnancy the 
nuMoM2b Substudy examined, the association between sleep 
duration, sleep timing, and continuity and key demographic 
factors, including age, race/ethnicity, BMI, insurance status, 
and prepregnancy smoking. Sleep duration was not associated 
with most demographic characteristics other than race/ethnicity 
and insurance status after adjustment. However, there was an 
association between sleep continuity, timing and variability, and 
demographic characteristics. For example, while after adjust-
ment, age was not significantly associated with sleep duration, 
Table 5—Actigraphic Measures of  Sleep Duration and Continuity Averaged Over 7 Days by Baseline Characteristics.
Baseline 
characteristic
Sample 
size
Time in bed,  
hours
Sleep duration,  
hours
Sleep fragmenta-
tion index
Sleep  
efficiency, %
Wake after sleep  
onset, minutes
Sleep Midpoint, 
hours:minutes
Median 
(IQR)
pa Median 
(IQR)
pa Median 
(IQR)
pa Median (IQR) pa Median  
(IQR)
p valuea Median  
(IQR)
p valuea
Overall 782 8.7 (1.1) 7.4 (1.0) 17.5 (7.6) 85.2 (6.9) 42.2 (23.4) 3:38 (1:40)
Maternal age,  
years
 <22 148 9.1 (1.3) <.0001 7.4 (1.1) .5063 19.7 (8.7) <.0001 82.0 (7.3) <.0001 50.9 (31.3) <.0001 4:33 (1:40) <.0001
 22–35 573 8.6 (1.1) 7.5 (0.9) 17.0 (7.2) 85.8 (6.2) 40.6 (21.1) 3:25 (1:28)
 >35 61 8.6 (1.1) 7.3 (0.8) 18.6 (8.2) 84.6 (6.7) 42.9 (20.9) 2:59 (1:19)
Race/ethnicity
  Non-Hispanic 
white
496 8.7 (1.0) .1140 7.5 (0.9) <.0001 16.4 (6.9) <.0001 86.6 (5.5) <.0001 39.9 (20.0) <.0001 3:19 (1:19) <.0001
  Non-Hispanic 
black
92 8.9 (1.5) 7.1 (1.0) 21.5 (7.8) 80.6 (6.5) 54.6 (30.4) 4:20 (1:54)
 Hispanic 122 8.8 (1.1) 7.4 (1.0) 18.5 (7.4) 83.4 (7.6) 47.0 (30.4) 4:15 (2:11)
 Asian 28 8.5 (1.3) 7.0 (1.0) 18.3 (8.1) 82.9 (7.8) 43.9 (21.8) 3:41 (1:23)
 Other 44 8.7 (1.4) 7.4 (1.3) 18.1 (9.5) 83.1 (7.4) 45.8 (24.6) 4:00 (2:02)
BMI, kg/m2
 <18.5 21 9.0 (1.1) .0939 7.7 (0.8) .3279 17.9 (8.8) <.0001 84.5 (7.9) <.0001 42.9 (35.7) <.0001 5:04 (2:07) .0029
 18.5 to <25 391 8.6 (1.0) 7.4 (0.9) 16.7 (7.3) 85.6 (6.9) 39.4 (20.9) 3:33 (1:22)
 25 to <30 194 8.8 (1.1) 7.5 (0.9) 17.5 (6.8) 86.0 (5.7) 42.8 (20.3) 3:34 (1:41)
 30 to <35 98 8.7 (1.3) 7.5 (1.0) 18.4 (7.3) 84.6 (6.6) 42.3 (21.8) 3:52 (2:02)
 ≥35 68 8.8 (1.4) 7.1 (1.2) 20.9 (7.5) 81.8 (7.8) 54.7 (26.4) 3:48 (2:26)
Insurance Status
 Commercial 564 8.6 (1.1) <.0001 7.4 (0.9) .2713 16.5 (7.1) <.0001 86.2 (6.2) <.0001 39.6 (19.7) <.0001 3:19 (1:19) <.0001
  Government/ 
Self-pay
214 9.0 (1.3) 7.5 (1.2) 19.8 (7.3) 82.1 (7.5) 51.7 (29.2) 4:30 (1:54)
Smoked during 
3 months prior  
to pregnancy:
 Yes 113 8.8 (1.4) .0818 7.3 (1.3) .4537 19.5 (7.7) <.0001 83.1 (6.0) <.0001 48.3 (21.1) <.0001 4:25 (2:15) <.0001
 No 669 8.7 (1.1) 7.5 (0.9) 17.0 (7.5) 85.6 (6.9) 41.0 (22.7) 3:32 (1:28)
Abbreviation: BMI, body mass index; IQR, Interquartile range.
aThe p values associated with Kruskal-Wallis tests.
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younger women (<22 years) had the highest WASO, lowest 
sleep efficiency, latest sleep midpoint, and most variable sleep.
Non-Hispanic black and Asian women had the shortest sleep 
duration, and non-Hispanic black women also had the worst sleep 
continuity and latest sleep midpoint. Our findings are in agree-
ment with similar results from nonpregnant cohorts.52–54 Adverse 
pregnancy outcomes such as preeclampsia and preterm birth are 
also more common among black women.55,56 The racial differ-
ences we documented in sleep duration, continuity, and timing 
may be contributing factors in this important health disparity.
Women who were obese (BMI ≥35) at screening had high 
sleep fragmentation, low sleep efficiency, and a long WASO; 
while sleep duration was not associated with BMI, obese 
women had a median sleep duration that was 36 minutes less 
than the lowest BMI group. It is possible given that obesity is a 
risk factor for sleep disordered breathing (SDB) that the level 
of sleep disturbance in the obese group could be due to SDB57 
which was not assessed as part of this Substudy. In contrast, 
women with a low BMI (<18.5) had the longest sleep duration 
but latest sleep midpoint by almost 1.5 hours.
Health-related behavior, like smoking in the 3 months prior 
to pregnancy, was not significantly associated with sleep dura-
tion, but it was associated with higher FI, lower sleep efficiency, 
later sleep midpoint, and greater variability in sleep duration 
after controlling for other factors. Overall, these findings sug-
gest that demographic characteristics are associated with sleep 
characteristics and should be considered when examining sleep 
during pregnancy.
While this is one of the first large-scale studies to systemat-
ically measure objective sleep during pregnancy using actigra-
phy, we recognize the limitations of the study. The gold standard 
for documenting sleep is polysomnography (PSG). The correla-
tion between actigraphy and PSG in measuring sleep duration 
has been shown to be high (0.7–0.97), and actigraphy is consid-
ered by the American Academy of Sleep Medicine to be a valid 
method to determine sleep patterns in healthy adult populations.58 
Table 6—Actigraphic Measures of  Variability in Sleep Duration and Timing Averaged Over 7 Days by Baseline Characteristics.
Baseline characteristic Sample 
size
Standard deviation  
of time in bed, minutes
Standard deviation  
of sleep duration, minutes
Standard deviation  
of sleep midpoint, minutes
Median (IQR) pa Median (IQR) pa Median (IQR) pa
Overall 782 67.9 (47.9) 62.6 (41.6) 48.6 (32.6)
Maternal age, years
 <22 148 90.2 (51.1) <.0001 81.3 (50.4) <.0001 61.0 (38.2) <.0001
 22–35 573 64.8 (46.4) 58.4 (38.7) 47.2 (31.8)
 >35 61 61.0 (34.0) 56.7 (29.0) 43.2 (23.9)
Race/ethnicity
 White Non-Hispanic 496 61.8 (44.2) <.0001 57.5 (36.8) <.0001 46.1 (31.7) <.0001
 Black Non-Hispanic 92 90.4 (52.6) 80.5 (47.7) 59.4 (35.6)
 Hispanic 122 81.1 (46.4) 72.5 (43.8) 53.3 (28.6)
 Asian 28 67.7 (26.6) 62.4 (29.5) 45.6 (25.9)
 Other 44 75.6 (51.5) 75.4 (54.8) 52.2 (43.7)
BMI, in kg/m2
 <18.5 21 85.1 (46.9) <.0001 68.8 (48.1) .0002 46.5 (25.4) .0499
 18.5 to <25 391 64.8 (44.4) 59.6 (36.5) 47.5 (32.0)
 25 to <30 194 67.8 (45.2) 61.8 (40.7) 47.9 (34.1)
 30 to <35 98 72.9 (53.3) 66.1 (51.5) 52.8 (36.5)
 ≥35 68 94.0 (63.5) 82.4 (47.4) 53.8 (43.2)
Insurance status
 Commercial 564 63.6 (43.6) <.0001 58.4 (36.0) <.0001 47.3 (32.2) .0056
 Government/Self-pay 214 87.5 (54.0) 77.9 (53.5) 52.2 (37.4)
Smoked during 3 months  
prior to pregnancy
 Yes 113 80.5 (56.3) .0002 74.2 (50.9) <.0001 54.9 (34.0) .0059
 No 669 66.8 (47.3) 60.7 (39.2) 47.8 (33.2)
Abbreviation: BMI, body mass index; IQR, Interquartile range.
aThe p values associated with Kruskal-Wallis tests.
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However, actigraphy does not measure sleep or wake directly 
and does not differentiate sleep stages. Given feasibility con-
straints and the advantages of having multiple day recordings, we 
believe that collecting sleep data with actigraphy is an appropri-
ate method and provides reliable information on habitual sleep 
patterns. A further limitation of this study is that the study design 
does not allow us to address the underlying cause of the sleep 
disturbance, which could be addressed in future studies.
This article also adds to the literature by describing the gen-
eral level of compliance with actigraphy (i.e., wearing the watch 
successfully) during the second trimester of pregnancy, includ-
ing the use of markers (i.e., event markers and daily sleep logs) 
to determine rest intervals. The majority (85%) of rest intervals 
had a useful marker at both the beginning and the end of the 
rest interval. Overall, with minimal incentive more than 85% of 
the women enrolled were able to provide usable data, suggest-
ing that actigraphy can be used successfully on a large scale to 
determine objective sleep in this population.
Given that the degree of sleep disturbance has been shown to 
vary as pregnancy progresses,18 assessing sleep at a single point 
in pregnancy could be considered a limitation. However, while 
objective assessment of sleep across pregnancy may be advan-
tageous, there are several reasons why sleep duration and con-
tinuity in the second trimester is likely to be important. First, 
studies have shown that many important physiological events 
(e.g., remodeling of maternal vessels and trophoblastic invasion) 
take place in the first and second trimester and that early changes 
in inflammatory, oxidative stress and metabolic pathways can 
adversely affect these physiologic processes and thereby lead 
to abnormal pregnancy development.59,60 Second, assessment 
too early (i.e., first trimester) might have decreased our ability 
to capture sleep disturbances that develop during the early sec-
ond trimester, as sleep often worsens as pregnancy progresses. 
Therefore, assessment of sleep in the mid-second trimester likely 
represents a time period when the probability of sleep distur-
bance is prevalent and yet early enough for assessing/screening 
for sleep problems to initiate interventions that optimize sleep.
In summary, in the second trimester of nulliparous pregnancy, 
sleep duration varies by race/ethnicity and insurance status, 
while sleep continuity and timing measures vary by race/eth-
nicity, age, BMI, insurance status, and recent smoking history. 
Given the known associations of short sleep duration, poor 
sleep continuity, and later sleep timing with poor cardiomet-
abolic health, further analysis of this cohort to investigate the 
association between sleep and adverse cardiometabolic mater-
nal and fetal pregnancy outcomes and how these may be influ-
enced by demographic characteristics is warranted.
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